Testing Radiation and HER2-targeted Therapy Versus HER2-targeted Therapy Alone for Low-risk HER2-positive Breast Cancer
Clinical trial NCT05705401 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05705401
- Sponsor
- NRG Oncology
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-19
- Primary completion
- 2034-02-01
- Enrollment
- 1300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.